Bruker Corporation
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Bruker Corporation's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Locked Ratio: For every $100 of sales, $44 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $44 tied up three years earlier. More money tied up than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$138Over the last 3 years, every $100 of reported profit came with $138 of operating cash.
Lower than 58% of Healthcare companies in United States.
Self-Funding Ratio
2.1×Over the last 3 years its own operating cash covered its investment spending (capex) 2.1 times.
Higher than 75% of Healthcare companies in United States.
Cash Locked Ratio
$44For every $100 of sales, $44 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $44 tied up three years earlier.
More money tied up than 86% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Steadier than 69% of Healthcare companies in United States.
Growth Efficiency Ratio
−$34Sales grew 36% in 3 years, but profit fell: $34 less profit per $100 of extra sales.
Lower than 80% of Healthcare companies in United States.
Asset Productivity Ratio
+36% / +73%In 3 years sales changed by +36% while total assets changed by +73%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
8.1×Debt due within a year is covered 8.1 times by its yearly operating cash.
Higher than 83% of Healthcare companies in United States.
Cash Cushion Ratio
−20%Debt, after subtracting cash, equals 20% of its market value (net debt).
Lower than 84% of Healthcare companies in United States.
Tangible Assets Ratio
61%Of every $100 the company owns, $61 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 69% of Healthcare companies in United States.
Tangible Net Worth Ratio
0%Of every $100 of net worth, $0 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 73% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Bruker Corporation made a loss over the last year. Bruker Corporation owes $0.60 for every $1 it owns. Bruker Corporation made a loss in the year to Dec 2025, after a profit the year before.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossBruker Corporation made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
3.68The share price is 3.68 times Bruker Corporation's book value per share, higher than 62% of Healthcare companies in United States.
Market cap
$8.8 BThe total market value of all of Bruker Corporation's shares at today's price (share price × number of shares), larger than 88% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$2.4 BWhat Bruker Corporation would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$15.63Net worth divided by the number of shares. The share price of $57.59 is 3.7 times this, which is the P/B above.
Return on equity (ROE)
-3.0%Bruker Corporation lost 3.0% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
Owes vs Owns
0.60×Bruker Corporation owes $0.60 for every $1 it owns (moderate), higher than 64% of Healthcare companies in United States.
Dividend yield
0.35%Bruker Corporation pays 0.35% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in United States.
Revenue growth
+2%Revenue rose 2% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Profit growth
LossBruker Corporation made a loss in the year to Dec 2025, after a profit the year before.
Profit margin
-0.3%Bruker Corporation lost $0 for every $100 of revenue.
Interest cover
3.9×Bruker Corporation's operating profit covered its interest costs 3.9 times in the year to Dec 2025.
Cash vs debt
Net debtBruker Corporation had $1.7 B more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Bruker Corporation: $8.8 B ÷ $2.4 B (30 Jun 2026) = 3.7.
What is Bruker Corporation's return on equity?
Bruker Corporation lost 3.0% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
How much does Bruker Corporation owe compared with what it owns?
Bruker Corporation owes $0.60 for every $1 it owns (moderate), higher than 64% of Healthcare companies in United States.
Does Bruker Corporation pay a dividend?
Yes. Bruker Corporation pays 0.35% of its share price as dividends a year, lower than 88% of dividend-paying Healthcare companies in United States.
Is Bruker Corporation's revenue growing?
Revenue rose 2% in the year to Dec 2025, and grew 11% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.